Modified brain cells tested to boost chemo against aggressive tumors
NCT ID NCT02192359
Summary
This early-stage study is testing a new two-part treatment for aggressive brain tumors that have returned after standard therapy. Doctors place genetically modified neural stem cells into the brain to make the tumor more sensitive to a chemotherapy drug called irinotecan. The main goal is to find the safest dose and understand the side effects in a small group of 18 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.